Uncategorized

Novo Nordisk’s Q1 in four words: Pills, pricing, payments and pressure

Novo Nordisk’s Q1 in four words: Pills, pricing, payments and pressure

Published

2 hours ago

on

A million patients with obesity are already taking Novo Nordisk’s Wegovy pill, CEO Mike Doustdar said Wednesday, despite the market entry of Lilly’s Foundayo.

Novo’s pill had sales of 2.3 billion Danish …​ ​Read More

Related Topics:

Leave a Reply

Your email address will not be published. Required fields are marked *

Trending

Exit mobile version